10 Stocks With At Least $10 Million In Insider Sales Recently

8. Tempus AI, Inc. (NASDAQ:TEM)

Highest Individual Sale: $19,293,002.93

Number of Sales Above $10 million: 6

Market Capitalization: $9.14 billion

Tempus AI is a health technology company focused on integrating artificial intelligence and machine learning to advance precision medicine. The Chicago, Illinois-based company boasts one of the world’s largest libraries of clinical and molecular data, supported by an operating system designed to make this data both accessible and actionable.

In February, Tempus AI completed its acquisition of Ambry Genetics, a leading player in genetic testing aimed at improving health through a deeper understanding of the connection between genetics and disease. The deal was valued at $375 million in cash and $225 million in stock, with $100 million of the stock subject to a lock-up agreement for one year after the transaction’s close.

For 2024, Tempus AI reported revenue of $693 million, reflecting a year-over-year growth of approximately 30%. In the fourth quarter, its revenue grew 35.7% to $200.7 million. The company attributed this strong revenue growth to market adoption of both genomic testing and data services. In the quarter, Tempus AI also delivered a 49.7% increase in gross profit.

Tempus AI went public in June 2024, and since then it returned 31.83% to its investors. It is also considered one of Wall Street’s top 10 AI stocks to watch right now.

Twelve analysts have an average “Moderate Buy” rating on Tempus AI stock, with a price target of $59.73, according to MarketBeat.